Bioceres Crop Solutions Corp. BIOX

Set alert

Price alert · BIOX

All alert types
0.22 USD +0.01 +3.16%

At close · Nov 2

0.23 0.00 +1.98%

After hours · Nov 2, 4:00 PM ET

Bid
0.21 × 8
Ask
0.24 × 2
0.2053 Day range 0.23
0.19 52-week range 2.04
YTD
-83.08%
1 year
-89.08%
Open
0.2149
Prev close
0.2149
Mkt cap
14.15M
Vol
432.16K
Avg vol
312.88K
EPS
-1.20
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2053
High
0.23
Forward P/E
9.88
Beta
0.47
Short ratio
3.12
Inst. own
23.71%
Dividend
0.00
Ex-div date
Earnings
Feb 13, 2025
50-d avg
6.74
200-d avg
9.83
1y target
12.13

5Y chart

Chart tools
Interval

Events in this range
  • Feb 8, 2024Earnings: —; estimate 0.07; surprise —%
  • Feb 8, 2024Earnings: 0; estimate 0.07; surprise —%
  • Sep 9, 2024Earnings: -0.03; estimate 0.2; surprise -115%
  • Sep 9, 2024Earnings: —; estimate 0.2; surprise —%
  • Sep 11, 2024Rating: Lake Street · Buy → Buy
  • Sep 11, 2024Rating: Roth MKM · Buy → Buy
  • Sep 11, 2024Rating: Canaccord Genuity · Buy → Buy
  • Oct 17, 2024Rating: Canaccord Genuity · Buy → Buy
  • Oct 21, 2024Rating: Oppenheimer · Outperform → Outperform
  • Nov 11, 2024Earnings: -0.09; estimate 0.02; surprise -550%
  • Nov 13, 2024Rating: Canaccord Genuity · Buy → Buy
  • Feb 13, 2025Earnings: —; estimate 0.14; surprise —%
Signals (83)
NameDateAgo
RSI: OversoldOct 19, 20262 weeks ago
SMA: BearishSep 14, 20261 month ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishApr 27, 20266 months ago
RSI: OversoldApr 20, 20266 months ago
SMA: BullishApr 6, 20267 months ago
RSI: OversoldJan 26, 20269 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 24, 202511 months ago
RSI: OversoldNov 17, 202511 months ago
SMA: BearishNov 3, 20251 year ago
SMA: BullishOct 27, 20251 year ago
MACD: Buy SignalOct 27, 20251 year ago
RSI: OversoldSep 1, 20251 year ago
MACD: Sell SignalAug 4, 20251 year ago
SMA: BearishJul 7, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 9, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 7, 20251 year ago

Newest 20 of 83.

Analyst view

Consensus: none

Price target (mean) 12.13 +5369.1% upside
Target (low)
9.50
Target (mean)
12.13
Target (high)
13.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BIOX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.150.11 – 0.200.00156+9515.4%144.63M+3.1%3
Next quarter-0.03-0.08 – 0.020.139-121.6%83.45M-0.6%3
Current year0.280.16 – 0.430.0502+457.8%463.43M-0.3%3
Next year0.5350.46 – 0.610.28+91.1%510.63M+10.2%2

Upgrades and downgrades

The latest rating changes

BIOX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024Canaccord GenuityMaintainedBuyBuy
Oct 21, 2024OppenheimerMaintainedOutperformOutperform
Oct 17, 2024Canaccord GenuityMaintainedBuyBuy
Sep 11, 2024Canaccord GenuityMaintainedBuyBuy
Sep 11, 2024Roth MKMMaintainedBuyBuy
Sep 11, 2024Lake StreetMaintainedBuyBuy
Sep 11, 2024OppenheimerMaintainedOutperformOutperform
Feb 9, 2024Roth MKMMaintainedBuyBuy
Nov 1, 2023Roth MKMMaintainedBuyBuy
Sep 12, 2023Lake StreetMaintainedBuyBuy
Sep 12, 2023Roth MKMReiteratedBuyBuy
Aug 16, 2023Roth MKMReiteratedBuyBuy
Apr 6, 2023OppenheimerInitiated—Outperform
Sep 30, 2022Canaccord GenuityInitiated—Buy
Oct 8, 2021Roth CapitalInitiated—Buy
Mar 15, 2021Lake StreetInitiated—Buy